Luxury wellness resorts are introducing specialized programs tailored for individuals taking GLP-1 medications like Ozempic and Mounjaro. These retreats, including Hilton Head Health, Pritikin Longevity Center, and Skyterra, combine fitness, nutrition counseling, and behavioral coaching to support long-term weight management. Costs for these weeklong stays can exceed $6,000, raising questions about whether such programming serves a medical purpose or functions as a high-end luxury trend.
Participants receive personalized guidance focused on muscle preservation and dietary habits, addressing common concerns regarding life after medication. Experts note that while the drugs reduce appetite and food noise, they do not automatically establish the healthy habits required for permanent weight loss. Clinics stress that these retreats provide a framework for patients to maintain muscle mass and prevent regaining weight should they transition off the medication in the future.
Stamie Giallourakis, who participated in the program at Hilton Head Health, sought these resources to build community and professional support. While she was the only person in the GLP-1 specific cohort during her stay, she found value in the individualized attention provided by nutritionists and fitness experts. The program aimed to shift the focus from the medication itself to broader lifestyle changes that support health across different stages of a weight loss timeline.
Critics argue that these resorts may capitalize on the popularity of weight loss drugs, noting that the services offered are often available through standard medical channels. Others suggest the retreats provide a necessary space for patients to develop sustainable routines that are often ignored in standard care. As the market for wellness tourism continues to grow, these facilities adapt their services to meet the specific requirements of a population that is increasingly utilizing medical interventions for weight management.